Why Wegovy Causes Nausea — and What That Actually Means for You

Nausea is the most commonly reported side effect of semaglutide: it tends to be mild to moderate, usually peaks in the first few weeks or after a dose step, and typically eases as the body adjusts.
The cause is pharmacological, not a sign that the medicine is harming you, slowed gastric emptying and central GLP-1 receptor activity both play a role.
Severe or persistent stomach pain that radiates to the back, with or without vomiting, is a separate signal that needs urgent medical attention: it may indicate pancreatitis, which the MHRA flagged in a January 2026 Drug Safety Update.
Suspected side effects, including reactions you are unsure about, can be reported directly to the MHRA at yellowcard.mhra.gov.uk.

Wegovy causes nausea because semaglutide slows the rate at which your stomach empties and activates GLP-1 receptors in the brain's appetite centres, triggering signals that your body initially interprets as unsettled. Most people experience this most noticeably in the first few weeks or after a dose increase, and for the majority it settles on its own. It can feel disheartening when it hits — you started treatment to feel better about your health, not worse at lunchtime. Wegovy is a prescription-only medicine, and a prescriber assesses whether it is suitable for you as part of any clinical consultation, including how to manage side effects if they arise.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Making sense of Wegovy nausea: what's driving it, how serious it is, and when to act

The decision you're probably weighing: push through the nausea or stop?

This is the question our prescribers hear most weeks. Someone is a few doses in, feeling queasy after meals, and wondering whether this is just part of the process or a reason to stop. The honest answer is that it depends on what kind of nausea you mean. Routine GLP-1 nausea (the low-grade, unsettled feeling that tends to come after eating too much or too quickly) is expected and generally manageable. It is not a sign the medicine is working against you; it is a direct consequence of how semaglutide works, and for most people it fades.

Semaglutide is a GLP-1 receptor agonist. GLP-1 is a hormone released naturally after eating; it slows gastric emptying (food moves out of the stomach more gradually), reduces appetite signals in the hypothalamus, and affects the brainstem's nausea pathways. When semaglutide activates those same receptors at a sustained level, the stomach adjusts more slowly than the brain, and the result is nausea. The NHS medicines information for semaglutide confirms this as the most commonly reported adverse effect. Read more about the full range of possible reactions on our Wegovy side effects overview.

The decision to continue or pause should involve your prescriber, not just a forum. Understanding what is driving the sensation (and distinguishing it from the warning signs below) is the most useful thing you can do right now.

Why the nausea follows the dose schedule

Wegovy's titration ladder exists largely because of gastrointestinal tolerability. The starting dose is 0.25 mg weekly, which is low enough for most people's stomachs to adapt before the dose steps up roughly every four weeks. Each increase re-exposes the gut to a higher level of receptor activation, which is why nausea can return briefly even after it had settled. This pattern (better for a few weeks, then a wobble at the next step) is common and is the reason the schedule is designed to move gradually.

Eating habits make a significant difference in practice. Smaller portions, slower eating, avoiding high-fat meals and steering clear of alcohol all reduce the severity of nausea. Staying well hydrated matters too, particularly if nausea has reduced your appetite for food and fluids. These are not cures, but they change the day-to-day experience meaningfully. Why semaglutide also causes fatigue in some people is a separate but related question, you can explore that on our page covering why semaglutide causes fatigue.

If nausea is severe enough to prevent eating or drinking at all, or if vomiting is frequent, that crosses from expected side effect into a clinical concern. Dehydration from persistent vomiting can affect kidney function, and this is a reason to contact your prescriber or GP rather than wait it out.

When to get medical help, and the signs that matter most

Most Wegovy-related nausea does not require an emergency call. But three patterns should prompt you to seek medical attention promptly, not just read on and hope for the best.

First, severe stomach pain that does not pass and extends through to the back, with or without vomiting, can be a sign of acute pancreatitis. This is an infrequent but serious reaction. In January 2026 the MHRA issued a Drug Safety Update for GLP-1 medicines specifically highlighting pancreatitis: the advice is to stop the medicine and seek urgent care if this pattern of pain develops.

Second, signs of significant dehydration (dizziness when standing, very dark urine, confusion) mean your body needs help sooner rather than later, especially if vomiting has been going on for more than a day.

Third, pain in the upper right abdomen that comes and goes, often after eating, can suggest a gallbladder problem. GLP-1 medicines are associated with a modest increase in gallstone risk, so this symptom deserves a GP review rather than reassurance from an article. Our page on managing nausea while taking Wegovy covers practical day-to-day strategies, but these three patterns sit outside what self-management can address. Diarrhoea is another gut symptom that catches people off guard, and if you have been experiencing that alongside nausea, our page explaining why Wegovy causes diarrhoea sets out the mechanism in plain terms. If anything feels wrong in a way you cannot explain, contact a clinician, that is not overcaution, it is exactly the right call.

Private treatment and what the clinical process looks like

Wegovy is a prescription-only medicine. The only legal route to it in the UK is a prescription issued following a proper clinical assessment, and any legitimate online service involves a real prescriber reviewing your answers, not a form that auto-approves. At nume, a GPhC-registered Independent Prescriber reads every consultation personally and discusses suitability including the side-effect profile. You can verify our pharmacy on the official register at GPhC registration 9012878.

If you are already on Wegovy and struggling with nausea, our prescribers are available for aftercare seven days a week. Side effects are a clinical conversation, not a problem to manage alone. If you are considering starting treatment and want to understand more about what to expect, the Wegovy treatment page covers the full picture, and our free consultation is the place to raise questions directly with a prescriber. Those exploring costs can find a factual breakdown on our Wegovy cost in the UK page. For an overview of all weight-management options we offer, the weight-loss treatments page sets them out plainly.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions